Vaccine Contract Manufacturing Global Market Report 2025

Global Vaccine Contract Manufacturing Market Report 2024

Vaccine Contract Manufacturing Global Market Report 2025 – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines), By Process (Downstream, Upstream), By Scale Of Operation (Preclinical, Clinical, Commercial), By End-Use (Human Use, Veterinary) – Market Size, Trends, And Global Forecast 2025-2034

Name: Vaccine Contract Manufacturing Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Vaccine Contract Manufacturing Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Vaccine Contract Manufacturing Global Market Report 2025

Proud Members Of

Vaccine Contract Manufacturing Market Definition

Vaccine contract manufacturing refers to an arrangement for creating vaccines with outside producers, who oversee producing, packing, and labeling vaccines according to the specifications and demands of the contracting business or organization. The primary benefit of vaccine contract manufacturing is that it simplifies production, resulting in cost savings and fewer difficulties.

The main types of services involved in vaccine contract manufacturing are fill-finish and bulk products. Fill-finish refers to the filling and finishing of the manufacturing process of vaccines. In the pharmaceutical industry, finishing refers to the sterilization and standardization of vaccine components into the containers, while filling means simply adding them to containers and sealing them properly. The vaccines produced are inactivated vaccines, live-attenuated vaccines, RNA (ribonucleic acid) vaccines, subunit vaccines, and toxoid-based vaccines. These are prepared by downstream and Upstream processes on preclinical, clinical, and commercial scales of operations for human use and veterinary end-users.

Vaccine Contract Manufacturing Market Segmentation

The vaccine contract manufacturing market covered in this report is segmented –

1) By Service Type: Fill-Finish, Bulk Product

2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines

3) By Process: Downstream, Upstream

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By End-Use: Human Use, Veterinary

Subsegments:

1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling

2) By Bulk Product: cell culture, Microbial Fermentation, Antigen Production, Buffer Preparation

Vaccine Contract Manufacturing Market Size and growth rate 2025 to 2029: Graph

Vaccine Contract Manufacturing Market Size 2025 And Growth Rate

The vaccine contract manufacturing market size has grown strongly in recent years. It will grow from $3.58 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to traditional vaccine manufacturing limitations, global disease outbreaks driving vaccine demand, regulatory support for contract manufacturing, increasing complexity of vaccine production, and surge in vaccine research and development

Vaccine Contract Manufacturing Market Growth Forecast

The vaccine contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $5.93 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to growing emphasis on pandemic preparedness, increased outsourcing in pharmaceutical manufacturing, expansion of biopharmaceutical companies, accelerated vaccine development timelines, global initiatives for vaccine accessibility. Major trends in the forecast period include integration of single-use technologies in manufacturing, rise in personalized medicine approaches to vaccine development, development of mRNA and viral vector vaccines, adoption of continuous manufacturing processes, expansion of fill-finish services.

Book your 30 minutes free consultation with our research experts

Vaccine Contract Manufacturing Market Driver: Rising Vaccination Initiatives Fuel Growth In The Vaccine Contract Manufacturing Market

An increase in initiatives favoring vaccinations is expected to propel the growth of the vaccine contract manufacturing market going forward. Vaccination refers to an easy, safe, and efficient method of defending against contagious diseases before they occur. It boosts the immune system and builds up the body's defenses against infections. Increasing initiatives favoring vaccinations would help advance and develop various vaccine manufacturing processes to support vaccine contract manufacturing. For instance, in November 2022, the U.S. Department of Health and Human Services, a US-based cabinet-level executive branch department of the federal government, announced a new $350 million initiative for HRSA (Health Resources and Services Administration)-supported health facilities to boost the number of COVID-19 vaccines in their communities, with an emphasis on marginalized people. Therefore, the increase in initiatives favoring vaccinations is driving the growth of the vaccine contract manufacturing market.

Vaccine Contract Manufacturing Market Driver: Elevated Infectious Disease Cases Propel Expansion In The Vaccine Contract Manufacturing Market

The rising infectious diseases worldwide are expected to boost the growth of the vaccine contract manufacturing market. Infectious diseases refer to disorders caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. When there is an outbreak of infectious diseases, such as influenza, measles, or emerging viruses, there is an urgent need for vaccines to prevent further spread. Contract manufacturers can quickly scale up production to respond to these outbreaks. For instance, in December 2022, according to the Office for National Statistics, a UK-based recognized national statistics institute the infection rate climbed for people aged 35 to 69 years and increased for those in school years 12 to 24 years. The total hospital admission rate for patients with confirmed COVID-19 in England increased to 9.56 per 100,000 individuals in England. The admission rate to intensive care units (ICUs) and high dependency units (HDUs) climbed to 0.29 per 100,000 inhabitants. Furthermore, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the rising infectious diseases worldwide are driving the growth of the vaccine contract manufacturing market.

Global Vaccine Contract Manufacturing Market Major Players

Major companies operating in the vaccine contract manufacturing market include Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L

Global Vaccine Contract Manufacturing Market Trend: Strategic Partnerships Drive Growth In The Vaccine Contract Manufacturing Market

Strategic partnerships are a key trend gaining popularity in the vaccine contract manufacturing market. Significant companies are partnering with the companies operating in the vaccine contract manufacturing market to sustain their position in the market. For instance, in January 2023, Vaxxas, an Australia-based biotechnology company that develops a novel needle-free vaccination technology, partnered with the Coalition for Epidemic Preparedness Innovations, a Norway-based foundation, to finance and coordinate the development of new vaccines and promote the development of Vaxxas' needle-free vaccine patch delivery technology in a project that may eliminate the frozen storage requirement for mRNA vaccines. Furthermore, In October 2024, LenioBio, a Germany-based Biotech company, partnered with ReciBioPharm, a US-based contract development and manufacturing organization (CDMO), to scale up its protein manufacturing capabilities and accelerate vaccine production. This partnership aligns with LenioBio’s strategy to expand the scope of its CEPI-funded project, which aims to demonstrate the speed and efficiency of its proprietary ALiCE protein expression technology in producing vaccine-related proteins for use in clinical trials.

Global Vaccine Contract Manufacturing Market Trend: Strategic Expansion With The Standalone Vaccine Contract Manufacturing Site

Major companies operating in the vaccine contract manufacturing market are focusing on the production site opening of vaccine contract manufacturing to sustain their position in the market. Production site opening of vaccine contract manufacturing refers to the establishment of a facility dedicated to the manufacturing and production of vaccines on a contractual basis. For instance, in September 2023, WuXi Vaccines, a China-based contract development and manufacturing organization (CDMO) specializing in vaccine discovery and production, launched its first standalone vaccine CDMO site in Suzhou, China. This expansion marks a milestone for the company, introducing increased capabilities for both drug substance and drug product manufacturing. WuXi Vaccines now offers a comprehensive range of services covering diverse vaccines, including process development, drug product development, and the production of clinical-scale drug substances (DS) and small-to-medium sterile drug products (DP). The new standalone site enhances WuXi Vaccines' capacity to contribute to the development and manufacturing of vaccines, playing a pivotal role in advancing global healthcare solutions.

Vaccine Contract Manufacturing Market Merger And Acquisition: SK Bioscience Of South Korea Finalizes Acquisition Of German CDMO IDT Biologika

In October 2024, SK bioscience, a South Korea-based vaccine and biotech company, acquired controlling stakes of IDT Biologika for approximately $244 million. This acquisition aligns with SK bioscience's strategy to accelerate growth and aims to drive consolidated sales to KRW 1 trillion (approximately USD 757.6 million) within the next five years. The company also plans to expand further with the launch of next-generation pneumococcal vaccines, positioning itself for continued financial improvement beyond 2028. IDT Biologika, a German-based company vaccine contract development and manufacturing organizations (CDMO).

Regional Outlook For The Global Vaccine Contract Manufacturing Market

North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vaccine contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vaccine Contract Manufacturing Market?

The vaccine contract manufacturing market consists of revenues earned by entities by providing services such as analytical, quality control studies, cell or virus banking, and cold chain services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vaccine contract manufacturing market also includes sales of synthetic vaccines and DNA (deoxyribonucleic acid) vaccines, which are used in providing vaccine contract manufacturing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Vaccine Contract Manufacturing Industry?

The vaccine contract manufacturing research report is one of a series of new reports from The Business Research Company that provides vaccine contract manufacturing market statistics, including the vaccine contract manufacturing industry's global market size, regional shares, competitors with vaccine contract manufacturing market share, detailed vaccine contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine contract manufacturing industry. This vaccine contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Vaccine Contract Manufacturing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.93 billion
Revenue Forecast In 2034	$5.93 billion
Growth Rate	CAGR of 10.8% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Service Type: Fill-Finish, Bulk Product 2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines 3) By Process: Downstream, Upstream 4) By Scale Of Operation: Preclinical, Clinical, Commercial 5) By End-Use: Human Use, Veterinary Subsegments: 1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling 2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Vaccine Contract Manufacturing Market Characteristics

3. Vaccine Contract Manufacturing Market Trends And Strategies

4. Vaccine Contract Manufacturing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Vaccine Contract Manufacturing Growth Analysis And Strategic Analysis Framework

5.1. Global Vaccine Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Vaccine Contract Manufacturing Market Growth Rate Analysis

5.4. Global Vaccine Contract Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Vaccine Contract Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Vaccine Contract Manufacturing Total Addressable Market (TAM)

6. Vaccine Contract Manufacturing Market Segmentation

6.1. Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fill-Finish

Bulk Product

6.2. Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Vaccines

Live-Attenuated Vaccines

RNA (Ribonucleic Acid) Vaccines

Subunit Vaccines

Toxoid-Based Vaccines

6.3. Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Downstream

Upstream

6.4. Global Vaccine Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical

Clinical

Commercial

6.5. Global Vaccine Contract Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Use

Veterinary

6.6. Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Aseptic Fill-Finish

Lyophilization

Vial Filling

Syringe Filling

6.7. Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Bulk Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell Culture

Microbial Fermentation

Antigen Production

Buffer Preparation

7. Vaccine Contract Manufacturing Market Regional And Country Analysis

7.1. Global Vaccine Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Vaccine Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vaccine Contract Manufacturing Market

8.1. Asia-Pacific Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vaccine Contract Manufacturing Market

9.1. China Vaccine Contract Manufacturing Market Overview

9.2. China Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vaccine Contract Manufacturing Market

10.1. India Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vaccine Contract Manufacturing Market

11.1. Japan Vaccine Contract Manufacturing Market Overview

11.2. Japan Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vaccine Contract Manufacturing Market

12.1. Australia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vaccine Contract Manufacturing Market

13.1. Indonesia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vaccine Contract Manufacturing Market

14.1. South Korea Vaccine Contract Manufacturing Market Overview

14.2. South Korea Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vaccine Contract Manufacturing Market

15.1. Western Europe Vaccine Contract Manufacturing Market Overview

15.2. Western Europe Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vaccine Contract Manufacturing Market

16.1. UK Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vaccine Contract Manufacturing Market

17.1. Germany Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vaccine Contract Manufacturing Market

18.1. France Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vaccine Contract Manufacturing Market

19.1. Italy Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vaccine Contract Manufacturing Market

20.1. Spain Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vaccine Contract Manufacturing Market

21.1. Eastern Europe Vaccine Contract Manufacturing Market Overview

21.2. Eastern Europe Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vaccine Contract Manufacturing Market

22.1. Russia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vaccine Contract Manufacturing Market

23.1. North America Vaccine Contract Manufacturing Market Overview

23.2. North America Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vaccine Contract Manufacturing Market

24.1. USA Vaccine Contract Manufacturing Market Overview

24.2. USA Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vaccine Contract Manufacturing Market

25.1. Canada Vaccine Contract Manufacturing Market Overview

25.2. Canada Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vaccine Contract Manufacturing Market

26.1. South America Vaccine Contract Manufacturing Market Overview

26.2. South America Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vaccine Contract Manufacturing Market

27.1. Brazil Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vaccine Contract Manufacturing Market

28.1. Middle East Vaccine Contract Manufacturing Market Overview

28.2. Middle East Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vaccine Contract Manufacturing Market

29.1. Africa Vaccine Contract Manufacturing Market Overview

29.2. Africa Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vaccine Contract Manufacturing Market Competitive Landscape And Company Profiles

30.1. Vaccine Contract Manufacturing Market Competitive Landscape

30.2. Vaccine Contract Manufacturing Market Company Profiles

30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis

31. Vaccine Contract Manufacturing Market Other Major And Innovative Companies

31.1. Merck KGaA

31.2. Fujifilm Holdings Corporation

31.3. Moderna

31.4. BioNTech

31.5. GSK Vaccines

31.6. AstraZeneca PLC

31.7. Ajinomoto Co. Inc.

31.8. Icon plc

31.9. Lonza Group AG

31.10. Cytiva

31.11. Catalent Inc.

31.12. Charles River Laboratories International Inc.

31.13. Serum Institute of India Pvt. Ltd

31.14. Samsung Biologics

31.15. WuXi Biologics

32. Global Vaccine Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vaccine Contract Manufacturing Market

34. Recent Developments In The Vaccine Contract Manufacturing Market

35. Vaccine Contract Manufacturing Market High Potential Countries, Segments and Strategies

35.1 Vaccine Contract Manufacturing Market In 2029 - Countries Offering Most New Opportunities

35.2 Vaccine Contract Manufacturing Market In 2029 - Segments Offering Most New Opportunities

35.3 Vaccine Contract Manufacturing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Vaccine Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Vaccine Contract Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Bulk Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Vaccine Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Vaccine Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc Financial Performance

Table 79: Johnson & Johnson Financial Performance

Table 80: AbbVie Inc. Financial Performance

Table 81: Sanofi Financial Performance

Table 82: GlaxoSmithKline Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Vaccine Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Vaccine Contract Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Bulk Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Vaccine Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Vaccine Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc Financial Performance

Figure 79: Johnson & Johnson Financial Performance

Figure 80: AbbVie Inc. Financial Performance

Figure 81: Sanofi Financial Performance

Figure 82: GlaxoSmithKline Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Immunity Boosting Food Products Market 2024 – By Product Source (Herbs And Species, Nuts And Seeds, Fruits And Vegetables, Dairy-Based Products, Prebiotics, Other Product Sources), By Form (Tablets, Capsules, Powder, Liquid, Other Forms), By Distribution Channel (Store-Based, Non-Store-Based), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Viral Vectors And Plasmid DNA Global Market Report 2025 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 – By Technique (Competitive Assay, Sandwich Assay, Multiplex Detection Assay), By Application (Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bi-Specific MAbS Global Market Report 2025 – By Type (Catumaxomab (Removab), Blinatumomab, Duligotumab, Emicizumab, Amivantamab, Faricimab, Teclistamab), By Product Type (In Vivo, In Vitro), By Indication (Cancer, Hemophilia A, Ophthalmic), By End Use (Hospitals, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2025 – By Product Type (Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables), By Consumables (Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables), By Application (Endocrinology, Oncology, Cardiology, Therapeutic Drug Development & Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications), By End Users (Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Orphan Drugs Global Market Report 2025 – By Therapy Area (Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), By Diseases Type (Oncology, Hematology, Neurology, Cardiovascular, Other Disease Types), By Drug Type (Biological, Non-Biological), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Drug Delivery Devices Global Market Report 2025 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Vaccine Contract Manufacturing market?

How will the Vaccine Contract Manufacturing market drivers and restraints affect the market dynamics? What forces will shape the Vaccine Contract Manufacturing industry going forward?

The Vaccine Contract Manufacturing market major growth driver - Rising Vaccination Initiatives Fuel Growth In The Vaccine Contract Manufacturing Market. For further insights on the Vaccine Contract Manufacturing market, request a sample here

What is the forecast market size or the forecast market value of the Vaccine Contract Manufacturing market?

The Vaccine Contract Manufacturing market size has grown strongly in recent years. The vaccine contract manufacturing market size has grown strongly in recent years. It will grow from $3.58 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to traditional vaccine manufacturing limitations, global disease outbreaks driving vaccine demand, regulatory support for contract manufacturing, increasing complexity of vaccine production, and surge in vaccine research and development The vaccine contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $5.93 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to growing emphasis on pandemic preparedness, increased outsourcing in pharmaceutical manufacturing, expansion of biopharmaceutical companies, accelerated vaccine development timelines, global initiatives for vaccine accessibility. Major trends in the forecast period include integration of single-use technologies in manufacturing, rise in personalized medicine approaches to vaccine development, development of mRNA and viral vector vaccines, adoption of continuous manufacturing processes, expansion of fill-finish services. For further insights on the Vaccine Contract Manufacturing market, request a sample here

How is the Vaccine Contract Manufacturing market segmented?

The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation For further insights on the Vaccine Contract Manufacturing market, request a sample here

Which region has the largest share of the Vaccine Contract Manufacturing market? What are the other regions covered in the report?

North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Vaccine Contract Manufacturing market, request a sample here.

Who are the major players in the Vaccine Contract Manufacturing market?

What are the key trends in the Vaccine Contract Manufacturing market?

Major trends in the Vaccine Contract Manufacturing market include Strategic Partnerships Drive Growth In The Vaccine Contract Manufacturing Market. For further insights on the Vaccine Contract Manufacturing market, request a sample here.

What are the major opportunities in the Vaccine Contract Manufacturing market? What are the strategies for the Vaccine Contract Manufacturing market?

For detailed insights on the major opportunities and strategies in the Vaccine Contract Manufacturing market, request a sample here.

How does the Vaccine Contract Manufacturing market relate to the overall economy and other similar markets?

For detailed insights on Vaccine Contract Manufacturing's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Vaccine Contract Manufacturing industry?

For detailed insights on the mergers and acquisitions in the Vaccine Contract Manufacturing industry, request a sample here.

What are the key dynamics influencing the Vaccine Contract Manufacturing market growth? SWOT analysis of the Vaccine Contract Manufacturing market.

For detailed insights on the key dynamics influencing the Vaccine Contract Manufacturing market growth and SWOT analysis of the Vaccine Contract Manufacturing industry, request a sample here.